Loading...
•
Sep 30, 2021
Globus Medical Q3 2021 Earnings Report
Globus Medical's Q3 2021 financial results were announced, showcasing growth in revenue and earnings despite COVID-related challenges.
Key Takeaways
Globus Medical reported a 6.3% increase in worldwide net sales, reaching $229.7 million. GAAP net income increased by 6.8% to $47.2 million, with a GAAP diluted EPS of $0.45 and a non-GAAP diluted EPS of $0.50. The company reaffirmed its full-year 2021 guidance of $950 million in net sales and non-GAAP diluted earnings per share of $2.00.
Worldwide net sales increased by 6.3% compared to Q3 2020, reaching $229.7 million.
GAAP net income for the quarter was $47.2 million, representing 20.6% of net sales.
GAAP diluted EPS was $0.45, and non-GAAP diluted EPS was $0.50.
The company reaffirmed its full-year 2021 guidance of $950 million in net sales and non-GAAP diluted earnings per share of $2.00.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company today reaffirmed its full year 2021 guidance of $950 million in net sales and non-GAAP diluted earnings per share of $2.00.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...